Cargando…
c-Met信号通道参与HGF诱导不同基因型非小细胞肺癌细胞株对吉非替尼耐药
BACKGROUND AND OBJECTIVE: It has been known that hepatocyte growth factor (HGF) induces gefitinib resistance in non-small cell lung cancer (NSCLC) cells. The possible mechanism may be related to the activation of the HGF receptor c-Met. The aim of this study is to investigate the involvement of c-Me...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000636/ https://www.ncbi.nlm.nih.gov/pubmed/24034993 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.09.05 |
Ejemplares similares
-
肝细胞生长因子诱导敏感非小细胞肺癌细胞对吉非替尼耐药及机制的研究
Publicado: (2013) -
干扰FOXC1逆转非小细胞肺癌吉非替尼耐药的作用
Publicado: (2021) -
烟草烟雾通过ROS/Sirt3/SOD2通路诱导NSCLC细胞吉非替尼耐药
por: Yawan, ZI, et al.
Publicado: (2023) -
TRIM24介导肺癌细胞吉非替尼耐药机制探讨
Publicado: (2016) -
吉非替尼治疗晚期非小细胞肺癌耐药后的进展模式分析
Publicado: (2013)